Abstract:Coronary artery disease treatments like coronary artery bypass grafting and percutaneous transluminal coronary angioplasty have several drawbacks, such as their invasive nature. Two main types of stents, bare metal stents (BMSs) and drug-eluting stents (DESs), are implemented to overcome these difficulties. The BMS offers strong mechanical support but can cause in-stent thrombosis and restenosis. Conventional DES, comprising a metal platform coated with drug-conjugated polymers, initially lowers restenosis but can cause early thrombosis and late in-stent restenosis. To overcome these limitations, biodegradable DESs are being explored to provide short-term support without long-term complications. However, biodegradable metal-based DES can trigger immunogenic reactions when degraded. The next generation of stents is shifting toward bioresorbable polymer-based DES because their degradation products are compatible with the metabolic system of the body. This review discusses the in vivo degradation mechanisms of bioresorbable polymers such as polyglycolic acid, polylactic acid, and polycaprolactone (PCL) acid polymers. It was observed that these polymers primarily degrade via ester bond hydrolysis, influenced by polymer properties such as molecular weight, morphology, glass transition temperature, and composition. Additionally, this overview highlights ongoing advancements in bioresorbable polymer-based scaffolds like DESolve[Formula: see text]NX and FANTOM[Formula: see text]. These bioresorbable scaffolds are fabricated from poly-L-lactide acid and desamino tyrosine-based polymers, respectively. Polylactic-co-glycolic acid-coated platinum–chromium stents have also demonstrated effective performance, being fully absorbed within 4–6 months postimplantation. Moreover, PCL acid-based drug-eluting bifurcation stents have shown promise in treating cardiovascular diseases. However, the review emphasizes the necessity for continued research to address the existing challenges and enhance patient outcomes.

Advances in the development of biodegradable coronary stents: A translational perspective

Coronary Bioresorbable metallic stents:Advancements and future perspectives

Bio-resorbable polymer stents: a review of material progress and prospects

The Development of Design and Manufacture Techniques for Bioresorbable Coronary Artery Stents

Development of Biodegradable Polymeric Stents for the Treatment of Cardiovascular Diseases

Biodegradable Stents for Coronary Artery Disease Treatment: Recent Advances and Future Perspectives

Research Progress in Biodegradable Metals for Stent Application

Recent Advances in Cardiovascular Stent for Treatment of In-Stent Restenosis: Mechanisms and Strategies

A Survey of Coronary Stents Development

A Review on Biodegradable Materials for Cardiovascular Stent Application

New Insights and Perspectives into Biodegradable Metals in Cardiovascular Stents: A Mini Review

Research Progress on Biodegradable Metallic Endovascular Stents

An overview of polymer-based-bioresorbable drug-eluting stents

A biodegradable metal‐polymer composite stent safe and effective on physiological and serum‐containing biomimetic conditions

3D Printing of Biodegradable Polymer Vascular Stents: A Review

3D-printed bioresorbable vascular stents: emerging frontiers in personalized cardiac care

Moving research direction in the field of metallic bioresorbable stents-A mini-review

Coronary Stent Materials and Coatings: A Technology and Performance Update

Advances in Study of Polymeric Bioabsorbable Coronary Stents

Stents: Biomechanics, Biomaterials, and Insights from Computational Modeling

Biliary stents for active materials and surface modification: Recent advances and future perspectives